Septo-optic dysplasia as a manifestation of valproic acid embryopathy
- 1 August 2001
- journal article
- case report
- Published by Wiley in Teratology
- Vol. 64 (2) , 83-86
- https://doi.org/10.1002/tera.1049
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cranial nerves and ganglia are altered after in vitro treatment of mouse embryos with valproic acid (VPA) and 4-en-VPADevelopmental Brain Research, 1996
- Fetal Valproate Syndrome: Clinical and Neuro‐developmental Features in Two Sibling PairsDevelopmental Medicine and Child Neurology, 1994
- Prevention of stroke with ticlopidineNeurology, 1992
- Septo-Optic Dysplasia in Two SiblingsAmerican Journal of Ophthalmology, 1990
- Verification of the fetal valproate syndrome phenotypeAmerican Journal of Medical Genetics, 1988
- IN-UTERO EXPOSURE TO VALPROATE AND NEURAL TUBE DEFECTSThe Lancet, 1986
- VALPROIC ACID AND SPINA BIFIDAThe Lancet, 1982
- CONGENITAL ANOMALIES IN CHILDREN OF EPILEPTIC MOTHERS AND FATHERSNeuropediatrics, 1980
- Transmission of valproic acid (Depakene) across theplacenta: Half-life of the drug in mother and babyThe Journal of Pediatrics, 1979
- Maternal anticonvulsants and optic nerve hypoplasia.British Journal of Ophthalmology, 1978